Colistin Therapy for Urinary Tract Infections Due to Multidrug-Resistant Bacteria: Experience at a Tertiary Academic Medical Center.
Saved in:
| Title: | Colistin Therapy for Urinary Tract Infections Due to Multidrug-Resistant Bacteria: Experience at a Tertiary Academic Medical Center. |
|---|---|
| Authors: | Aldairem A; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Alowais SA; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Alshaya AI; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.; Collaboration and Partnerships Department, King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia., Alrashed M; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Alqahtani T; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; College of Pharmacy, Department of Pharmaceutical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Department of Preclinical Studies, Benefit and Risk Assessment Executive Directorate, Drug Sector, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia., Alharbi L; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alshehri R; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Al Dughaish ST; Clinical Pharmacy Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia., Alenazi A; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Bin Saleh K; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia. |
| Source: | Infection and drug resistance [Infect Drug Resist] 2026 May 25; Vol. 19, pp. 608721. Date of Electronic Publication: 2026 May 25 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101550216 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6973 (Print) Linking ISSN: 11786973 NLM ISO Abbreviation: Infect Drug Resist Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42222029 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Colistin Therapy for Urinary Tract Infections Due to Multidrug-Resistant Bacteria: Experience at a Tertiary Academic Medical Center. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Aldairem+A%22">Aldairem A</searchLink>; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alowais+SA%22">Alowais SA</searchLink>; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alshaya+AI%22">Alshaya AI</searchLink>; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.; Collaboration and Partnerships Department, King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alrashed+M%22">Alrashed M</searchLink>; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alqahtani+T%22">Alqahtani T</searchLink>; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; College of Pharmacy, Department of Pharmaceutical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Department of Preclinical Studies, Benefit and Risk Assessment Executive Directorate, Drug Sector, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alharbi+L%22">Alharbi L</searchLink>; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alshehri+R%22">Alshehri R</searchLink>; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Al+Dughaish+ST%22">Al Dughaish ST</searchLink>; Clinical Pharmacy Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Alenazi+A%22">Alenazi A</searchLink>; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Bin+Saleh+K%22">Bin Saleh K</searchLink>; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101550216%22">Infection and drug resistance</searchLink> [Infect Drug Resist] 2026 May 25; Vol. 19, pp. 608721. <i>Date of Electronic Publication: </i>2026 May 25 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101550216 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1178-6973 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211786973%22">11786973 </searchLink><i>NLM ISO Abbreviation: </i>Infect Drug Resist <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42222029 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2147/IDR.S608721 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 608721 Titles: – TitleFull: Colistin Therapy for Urinary Tract Infections Due to Multidrug-Resistant Bacteria: Experience at a Tertiary Academic Medical Center. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aldairem A – PersonEntity: Name: NameFull: Alowais SA – PersonEntity: Name: NameFull: Alshaya AI – PersonEntity: Name: NameFull: Alrashed M – PersonEntity: Name: NameFull: Alqahtani T – PersonEntity: Name: NameFull: Alharbi L – PersonEntity: Name: NameFull: Alshehri R – PersonEntity: Name: NameFull: Al Dughaish ST – PersonEntity: Name: NameFull: Alenazi A – PersonEntity: Name: NameFull: Bin Saleh K IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 05 Text: 2026 May 25 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 1178-6973 Numbering: – Type: volume Value: 19 Titles: – TitleFull: Infection and drug resistance Type: main |
| ResultId | 1 |